"Association between tumor heterogeneity and progression-free survival in ..."

Jiangdian Song et al. (2016)

> Home

Details and statistics

DOI: 10.1109/EMBC.2016.7590937

access: closed

type: Conference or Workshop Paper

metadata version: 2024-10-06

- view
  - electronic edition via DOI
  - unpaywalled version
  authority control:
- export record
  dblp key:
  - conf/embc/SongDHZLT16
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/conf/embc/SongDHZLT16
Jiangdian Song, Di Dong, Yanqi Huang, Yali Zang, Zaiyi Liu, Jie Tian:
Association between tumor heterogeneity and progression-free survival in non-small cell lung cancer patients with EGFR mutations undergoing tyrosine kinase inhibitors therapy. EMBC 2016: 1268-1271

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.